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On page 587, please note that [Table 1](#t1-vhrm-10-649){ref-type="table"} was incorrect. The correct table is provided below:

###### 

Characteristics of subjects with and without diabetic complications

                              Case subjects[\*](#tfn2-vhrm-10-649){ref-type="table-fn"}   Control subjects   *P*
  --------------------------- ----------------------------------------------------------- ------------------ --------------
  n                           217                                                         60                 
  Age (years)                 63.4±12.0                                                   54.1±13.6          \<**0.0001**
  Diabetes duration (years)   9 (3\~17)                                                   4 (1\~11)          **0.0029**
  Males (%)                   60.8%                                                       70.0%              0.1933
  BMI (kg/m^2^)               26.3±4.9                                                    25.9±5.3           0.5466
  HbA~1c~ (%)                 8.7±2.0 (71.6)                                              8.5±2.3 (69.4)     0.4404
  SBP (mmHg)                  136.4±19.6                                                  130.3±16.8         **0.0270**
  DBP (mmHg)                  79.0±12.5                                                   77.7±10.4          0.4525
  Total cholesterol (mg/dL)   195.1±37.9                                                  199.0±49.8         0.5918
  LDL cholesterol (mg/dL)     117.2±33.6                                                  122.8±37.7         0.2733
  HDL cholesterol (mg/dL)     55.1±16.1                                                   56.9±17.3          0.4528
  Triglycerides (mg/dL)       140 (104\~214)                                              151 (107\~231)     0.7500
  NT-proBNP (pg/mL)           59 (26\~140)                                                33 (16\~58)        \<**0.0001**
  Smoking (%)                 24.2%                                                       24.4%              0.5040
  Albuminuria (μg/min)        24.9 (9.0\~92.8)                                            8.2 (5.4\~15.7)    \<**0.0001**
  PWVR (cm/sec)               1,788±431                                                   1,504±301          \<**0.0001**
  PWVL (cm/sec)               1,813±568                                                   1,522±303          0.0003
  ABIR                        1.12±0.14                                                   1.14±0.08          0.4128
  ABIL                        1.11±0.14                                                   1.14±0.09          0.0939
  LVH (mm)                    26.1±8.7                                                    24.9±6.5           0.3652
  eGFR (mL/min/1.73m^2^)      71.6±23.5                                                   79.8±20.4          **0.0147**

**Notes:** Data are mean ± SD.

Presence of any of diabetic complications (DMR, nephropathy, DSN, CVD, and PAD). *P*-values in bold were demonstrated to have adequate effect size.

**Abbreviations:** BMI, body mass index; HbA~1c~, hemoglobin A~1c~; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; NT-proBNP, N-terminal fragment of probrain natriuretic peptide; IMTL, intima media thickness of left carotid; IMTR, intima media thickness of right carotid; PWV, pulse wave velocity; ABI, ankle brachial index; LVH, left ventricular hypertrophy; eGFR, estimated glomerular filtration rate; R, right; L, left; SD, standard deviation; CVD, cardiovascular disease; PAD, peripheral artery disease; DMR, diabetes mellitus retinopathy; DSN, distal sensory neuropathy.
